Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Xiangxue to Build Cell-Therapy Manufacturing Plant in Guangzhou

publication date: Jun 8, 2018

Xiangxue Pharma (XPH) announced plans to build a cell-therapy production facility in Guangzhou using GE Healthcare's prefabricated FlexFactory™ technology. The company will offer CDMO manufacturing services to other pharmas. Although known mainly for its TCM products, XPH has a subsidiary, Xiangxue Life Sciences (XLifeSc), that provides technology to develop T cell receptor products. GE said the XPH factory, which will be operational in March 2019, is the first use of its prefab factory for T Cell products. More details....

Stock Symbol: (SHE: 300147)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.